Philips Headquarters Cambridge recalls

Philips Headquarters Cambridge has 4 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 31 May 2023. 4 are still ongoing.

Total recalls4since 2023

Last 12 months0reported

Class I00% of total

Ongoing4latest 31 May 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 4 100%Class III 0 0%

Why philips headquarters cambridge is recalled

Other Reasons4100%

Product types

Imaging Equipment4100%

By year

20234100%

Ongoing philips headquarters cambridge recalls

4 active

Reported	Class	Recall	Company	Reason	Where
31 May 2023Device	CLASS II	Incisive CT Power- Whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states
31 May 2023Device	CLASS II	Incisive CT Plus -Whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states
31 May 2023Device	CLASS II	Incisive CT- Whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states
31 May 2023Device	CLASS II	Incisive CT- whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states

All philips headquarters cambridge recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
31 May 2023Device	CLASS II	Incisive CT Power- Whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states
31 May 2023Device	CLASS II	Incisive CT Plus -Whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states
31 May 2023Device	CLASS II	Incisive CT- Whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states
31 May 2023Device	CLASS II	Incisive CT- whole-body computed tomography (CT) X-Ray System recalled	Philips Headquarters Cambridge	Other	4 states

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.